NovoSynth Pharmaceuticals LLC

Company Description

NovoSynth Pharmaceuticals is a knowledge based and a customer focused company, supporting clients across the value chain: R&D, Manufacturing, Sales & Marketing. NovoSynth Pharmaceuticals LLC enable the faster / more effective advancement of our clients' commercialization efforts: (i) Open doors to collaborations across the value chain, globally (ii) Supporting CMC and Supply-Chain management activities (iii) Facilitate the introduction of products and services to new markets. We have presence in US, Europe & China and direct access to pharmaceutical suppliers and manufacturers. Our network of chemical suppliers and service providers can work together to meet our customers' speed to market objectives and deliver quality, security of supply and cost competitiveness

Company Information

  • Contact Person:Ms. Olena Angiulli
  • Department:CEO
  • Telephone:
  • Zip:19702
  • Business Type:Business Services
  • Year Established:2010
  • Number Of Employees:1-5
  • Trade Capacity:Export Percentage:
  • Production Capacity:1
  • R&D Capacity:Less than 5 people
  • Quality Control:In House
  • No. of QC Staff:Less than 5 people
  • Registered Capital:Less than 1 Million USD
  • Total Annual Sales Volume:Less than 1 Million USD
  • Main Products:Insulin
  • Address:13 Hempstead DrZ Suite 700, Newark, DE, USA
  • Main Markets:Americas,Asia,East Europe,Middle East
  • Website:Visit website

Product

  • Insulin
Countries   China   India   Indonesia   Malaysia   Pakistan   Turkey   United Kingdom   United States   All Countries